Skip to main content
. 2018 Feb 6;11(1):16. doi: 10.3390/ph11010016

Figure 4.

Figure 4

Comparison of mean tumor volumes (±SEM) in mice with human NSCLC. NCI-H460 implants treated with NUC050, NUC052 or gemcitabine (n =10 per group). SC mice are those treated contemporaneously with NUC050, NUC052 or gemcitabine 120/80 mg/kg as per regimen in Figure 3. Historic SC mice were from a previous experiment comparing SC to gemcitabine 135 mg/kg IV q5d × 3.